We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
101
Fiserv Inc
FISV
$29B
$11.5M 0.08%
99,053
-973
-1% -$107K
ADI icon
102
Analog Devices
ADI
$185B
$11.4M 0.08%
95,661
-537
-0.6% -$60.5K
ROP icon
103
Roper Technologies
ROP
$39.1B
$11.1M 0.08%
31,221
-2,181
-7% -$753K
CSGS
104
DELISTED
CSG Systems International
CSGS
$10.5M 0.07%
203,469
+4,547
+2% +$245K
FFBC icon
105
First Financial Bancorp
FFBC
$3.61B
$10.5M 0.07%
411,698
+7,108
+2% +$173K
EHC icon
106
Encompass Health
EHC
$11B
$10M 0.07%
182,144
+5,458
+3% +$296K
V icon
107
Visa
V
$688B
$9.98M 0.07%
53,124
-810
-2% -$146K
LCII icon
108
LCI Industries
LCII
$2.62B
$9.97M 0.07%
93,077
+2,508
+3% +$254K
RMD icon
109
ResMed
RMD
$32.6B
$9.53M 0.07%
61,492
-2,076
-3% -$299K
HAS icon
110
Hasbro
HAS
$12.9B
$9.42M 0.07%
89,201
+12,956
+17% +$1.35M
MSA icon
111
Mine Safety
MSA
$7.49B
$9.3M 0.06%
73,581
-5,525
-7% -$665K
ELS icon
112
Equity Lifestyle Properties
ELS
$12.6B
$9.22M 0.06%
131,050
+3,802
+3% +$264K
CBU icon
113
Community Bank
CBU
$3.5B
$8.98M 0.06%
126,590
+2,702
+2% +$181K
HMN icon
114
Horace Mann Educators
HMN
$2.1B
$8.89M 0.06%
203,604
+4,244
+2% +$188K
CE icon
115
Celanese
CE
$4.73B
$8.87M 0.06%
72,038
+3,473
+5% +$427K
G icon
116
Genpact
G
$6B
$8.55M 0.06%
202,829
+179,852
+783% +$7.19M
LMAT icon
117
LeMaitre Vascular
LMAT
$1.84B
$8.27M 0.06%
230,007
-1,821
-0.8% -$62.8K
XLNX
118
DELISTED
Xilinx Inc
XLNX
$7.64M 0.05%
78,138
-2,440
-3% -$229K
LOW icon
119
Lowe's Companies
LOW
$123B
$7.63M 0.05%
63,741
-447
-0.7% -$51.1K
TCF
120
DELISTED
TCF Financial Corporation Common Stock
TCF
$7.56M 0.05%
161,486
+17,225
+12% +$715K
COR
121
DELISTED
Coresite Realty Corporation
COR
$6.93M 0.05%
61,795
+12,954
+27% +$1.5M
NXST icon
122
Nexstar Media Group
NXST
$5.81B
$6.75M 0.05%
57,559
+1,058
+2% +$111K
DOX icon
123
Amdocs
DOX
$5.87B
$6.62M 0.05%
91,661
+3,630
+4% +$247K
LHX icon
124
L3Harris
LHX
$53.3B
$6.59M 0.05%
33,308
+31,675
+1,940% +$6.35M
DOW icon
125
Dow Inc
DOW
$21.5B
$6.54M 0.05%
119,537
-13,245
-10% -$684K

Similar funds

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.